INSERTIONAL INACTIVATION OF THE LARGE SUBUNIT OF RIBONUCLEOTIDE REDUCTASE ENCODED BY VACCINIA VIRUS IS ASSOCIATED WITH REDUCED VIRULENCE INVIVO

被引:65
作者
CHILD, SJ
PALUMBO, GJ
BULLER, RML
HRUBY, DE
机构
[1] OREGON STATE UNIV,DEPT MICROBIOL,CTR GENE RES,CORVALLIS,OR 97331
[2] NIAID,VIRAL DIS LAB,BETHESDA,MD 20892
关键词
D O I
10.1016/0042-6822(90)90119-C
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
To assess whether a fully functional VV ribonucleotide reductase enzyme is required during both in vitro and in vivo replication of VV, three mutant viruses were constructed by marker transfer techniques: M1λ, an M1 insertion mutant; TK-, an insertion mutant of the W thymidine kinase (tk) gene; and M1λ/TK-, a double mutant. Extracts of cells infected with the M1λ or Miλ/TK- mutant viruses were assayed for ribonucleotide reductase activity and it was found that insertional inactivation of the M 1 gene abolished the induction of viral enzyme activity in W-infected cells. Each of the three mutant viruses replicated to levels comparable to the wild-type (WT) virus in BSC40 (monkey), growing A549 (human lung carcinoma) cells, and serum-starved A549 cells, indicating that a functional M1 gene was not required for viral replication in tissue culture. In contrast, in vivo studies indicate that the loss of viral ribonucleotide reductase activity leads to a mild attenuation of VV. By the intracranial route of inoculation, approximately 10-fold more of the M1λ recombinant than the WT virus was required to produce the average lethal dose for 50% of the population of injected mice. © 1990.
引用
收藏
页码:625 / 629
页数:5
相关论文
共 33 条
[1]   IMMUNOLOGICAL CHARACTERIZATION OF HERPES-SIMPLEX VIRUS TYPE-1 AND TYPE-2 POLYPEPTIDE(S) INVOLVED IN VIRAL RIBONUCLEOTIDE REDUCTASE-ACTIVITY [J].
BACCHETTI, S ;
EVELEGH, MJ ;
MUIRHEAD, B ;
SARTORI, CS ;
HUSZAR, D .
JOURNAL OF VIROLOGY, 1984, 49 (02) :591-593
[2]   DNA NICKING-CLOSING ENZYME ENCAPSIDATED IN VACCINIA VIRUS - PARTIAL-PURIFICATION AND PROPERTIES [J].
BAUER, WR ;
RESSNER, EC ;
KATES, J ;
PATZKE, JV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1977, 74 (05) :1841-1845
[3]   RECOMBINANT VACCINIA VIRUSES AS VACCINES [J].
BROWN, F ;
SCHILD, GC ;
ADA, GL .
NATURE, 1986, 319 (6054) :549-550
[4]   DELETION OF THE VACCINIA VIRUS GROWTH-FACTOR GENE REDUCES VIRUS VIRULENCE [J].
BULLER, RML ;
CHAKRABARTI, S ;
COOPER, JA ;
TWARDZIK, DR ;
MOSS, B .
JOURNAL OF VIROLOGY, 1988, 62 (03) :866-874
[5]   DECREASED VIRULENCE OF RECOMBINANT VACCINIA VIRUS EXPRESSION VECTORS IS ASSOCIATED WITH A THYMIDINE KINASE-NEGATIVE PHENOTYPE [J].
BULLER, RML ;
SMITH, GL ;
CREMER, K ;
NOTKINS, AL ;
MOSS, B .
NATURE, 1985, 317 (6040) :813-815
[6]  
BULLER RML, 1985, LAB ANIM SCI, V35, P473
[7]  
CHALLBERG MD, 1979, J BIOL CHEM, V254, P7812
[8]   IDENTIFICATION, DEVELOPMENT, AND REGIONAL DISTRIBUTION OF RIBONUCLEOTIDE REDUCTASE IN ADULT-RAT BRAIN [J].
EELLS, JT ;
SPECTOR, R .
JOURNAL OF NEUROCHEMISTRY, 1983, 40 (04) :1008-1012
[9]  
ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114
[10]   IMMUNOCYTOCHEMICAL EVIDENCE FOR THE CYTOPLASMIC LOCALIZATION AND DIFFERENTIAL EXPRESSION DURING THE CELL-CYCLE OF THE M1-SUBUNIT AND M2-SUBUNIT OF MAMMALIAN RIBONUCLEOTIDE REDUCTASE [J].
ENGSTROM, Y ;
ROZELL, B .
EMBO JOURNAL, 1988, 7 (06) :1615-1620